# Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC

> **NCT01024829** · NA · UNKNOWN · sponsor: **The Netherlands Cancer Institute** · enrollment: 150 (actual)

## Conditions studied

- NSCLC

## Interventions

- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT01024829
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2020-12
- **Final completion:** 2022-03
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2022-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01024829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01024829, "Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01024829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*